ClinicalTrials.gg
Not yet recruitingNCT07937618Updated Nov 16, 2026

The Effect of Quadro-Iliaca Plane Block on Quality of Recovery Following Laparoscopic Inguinal Hernia Repair

An interventional study of Quadro iliac Plane Block and control gruop in Postoperative Pain, sponsored by Konya City Hospital. Not yet recruiting. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Konya City Hospital · Not applicable, Interventional, and Other

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 22 studies in Pain, Postoperative by Konya City Hospital — 11 open to participants now, 11 under way, none of them phase 3. Pain, Postoperative · Konya City Hospital.

Planned enrollment
5th of 18
88 · median 73
Started
2026
with 7 others
No phase
17 of 22
9 open now
Primary completion
2027-02
later than 6 of 10 live
Registered
22nd of 22
by date

Among the 22 studies in Pain, Postoperative by Konya City Hospital, this one is the 5th largest by planned enrollment of the 18 interventional ones that give a count, is one of 8 that started in 2026, is one of 17 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 22nd registered.

Pain, Postoperative

5,654 studies on the registry are indexed under Pain, Postoperative; 1,231 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

11 of the 22 studies in Pain, Postoperative by Konya City Hospital are open now, in 1 country. Recruiting first, the newest first:

5 more — sign in →

By country, each count listing its studies:

All 11 open studies →

Where they have run

Who these studies take

Of the 679 Pain, Postoperative studies recruiting now, 240 (35%) set no upper age limit and 329 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Pain, Postoperative by Konya City Hospital, or all of them as a file.
02

Study summary

The primary aim of this study is to evaluate the effects of quadro iliaca plane block on postoperative recovery in patients undergoing laparoscopic inguinal hernia surgery using the Quality of recovery-15 score. The secondary aim is to evaluate the numeric rating scale, total rescue analgesic intake, time to first rescue analgesic administration, patient satisfaction, complications such as nausea and vomiting, and antiemetic requirements in patients undergoing laparoscopic inguinal hernia surgery who underwent quadro iliaca plane block treatment, both at rest and in the mobilized state.

03

Conditions studied

  • Postoperative Pain

Browse trials for

Keywords

  • quadro iliaca plane block
  • postoperative pain
  • inguinal hernia repair
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18-65 years.
  • Patients classified as (ASA) physical status I-III.
  • Patients scheduled for elective unilateral laparoscopic inguinal hernia repair under general anesthesia.
  • Patients with sufficient cognitive and communication abilities to provide .
  • Patients who voluntarily agree to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Patients who do not want to give consent
  • Patients for whom regional anesthesia is
  • Patients with abnormal bleeding profiles
  • Patients with infection in the area where the block will be performed
  • Pregnant women and emergency cases will be excluded from the study.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
88 participants (estimated)

Study arms

  • Other
    Control Group

    Patients in this group will receive only intravenous analgesia (IV Paracetamol 1 g 3 times a day + Tenoxicam 20 mg 2 times a day). There will be a total of 44 patients in this group.

    Other: Quadro iliac Plane Block

  • Other
    quadro ilica plane block

    Other: control gruop

Interventions

  • OtherQuadro iliac Plane Block

    The block procedure will be performed after surgery is complete, while the patient is still under general anesthesia, before extubation, with the patient in a lateral position. A low-frequency convex transducer and a 100 mm block needle will be used. After sterilizing the lumbar region and ultrasound probe, the transducer will be placed parasagittally at the distal attachment of the quadratus lumborum muscle (QLM) to the iliac crest. The iliac crest and QLM will be visualized. The erector spinae muscle will be visualized above the QLM and the psoas major muscle below the QLM. Using an in-plane technique, the needle will be guided towards the iliac crest. At this level, 5 mL of isotonic saline sodium chlorohydrate will be injected into the interfascial space between the ESM and QLM for confirmation. After confirming the block site, 20 mL of local anesthetic solution containing 0.25% bupivacaine will be injected with intermittent aspirations.

  • Othercontrol gruop

    Patients in this group will only receive intravenous analgesia (IV Paracetamol 1 g 3 times a day + Tenoxicam 20 mg 2 times a day). There will be a total of 44 patients in this group.

06

What researchers measure

Primary outcomes

  1. Quality of recovery -15 score

    The quality of recovery -15 questionnaire is a short postoperative recovery scale developed and validated by Stark et al. in 2013. The quality of recovery -15 questionnaire contains 15 questions assessing pain, physical comfort, physical independence, psychological support, and emotional state. The answers to the questions are recorded as 10 always, 0 never. The test result is a score between 0 and 150, with a higher score indicating better recovery quality.

    Time frame: one day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — This can be requested from the relevant author if necessary.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

Of 2,096 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 3 months is below that.

Counting every sponsor, half of 2,109 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 16, 2026
StartEst.
Nov 20, 2026
Primary completionEst.
Feb 20, 2027
CompletionEst.
Feb 20, 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937618
Lead sponsor
Konya City Hospital
Responsible party
Muhammed Halit Satici (ASSOC PROF., Konya City Hospital) — Principal investigator
First posted
Nov 16, 2026
Start date
Nov 20, 2026 (estimated)
Primary completion
Feb 20, 2027 (estimated)
Completion
Feb 20, 2027 (estimated)
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion